Eleven Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
31
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
7
Eleven Therapeutics General Information
Description
Developer of an extended durability mRNA therapeutics designed to transform ribonucleic acid drug development into a programmable processor. The company's pipeline is dedicated to tackling unmet medical needs in the realms of metabolic, endocrinologic, and infectious diseases by the utilization of proprietary high-throughput AI-enabled screening platforms, strategically employed to enhance the stability and facilitate their targeted and selective delivery, enabling scientists to have fully programmable ribonucleic acid molecules with superior durability and specificity.
Contact Information
Website
www.scionxbio.comCorporate Office
- CRUK Cambridge Institute
- Robinson Way
- Cambridge CB2 0RE
- England, United Kingdom
Corporate Office
- CRUK Cambridge Institute
- Robinson Way
- Cambridge CB2 0RE
- England, United Kingdom
Eleven Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 4. Seed Round | 02-Aug-2022 | Completed | Generating Revenue | |||
| 3. Grant | 18-Dec-2021 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jun-2021 | $3.9M | Completed | Generating Revenue | ||
| 1. Seed Round | 01-Apr-2021 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Eleven Therapeutics Comparisons
Industry
Financing
Details
Eleven Therapeutics Competitors (3)
One of Eleven Therapeutics’s 3 competitors is FibroGen (China), a Corporate Backed or Acquired company based in Beijing, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| FibroGen (China) | Corporate Backed or Acquired | Beijing, China | ||||
| Avalyn Pharma | Formerly VC-backed | Boston, MA | ||||
| Kyntra Bio | Formerly VC-backed | San Francisco, CA |
Eleven Therapeutics Patents
Eleven Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025141025-A2 | Novel capping strategies for mrna 5'cap | Inactive | 26-Dec-2023 | ||
| WO-2025141025-A3 | Novel capping strategies for mrna 5'cap | Inactive | 26-Dec-2023 | ||
| EP-4746924-A1 | Non-natural building blocks for enhanced translation and stability of mrna | Pending | 17-Jul-2023 | ||
| WO-2025017029-A1 | Non-natural building blocks for enhanced translation and stability of mrna | Inactive | 17-Jul-2023 | ||
| WO-2024261215-A1 | High throughput screens of translation and stability of mrna using barcoded xrna display and its variations | Inactive | 22-Jun-2023 | C12N15/1062 |
Eleven Therapeutics Signals
Eleven Therapeutics Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Innovate UK | Government | Minority | ||
| Gates Foundation | Not-For-Profit Venture Capital | |||
| Entrée Capital | Venture Capital | Minority | ||
| Kindred Capital | Venture Capital | Minority | ||
| NFX | Venture Capital | Minority |
Eleven Therapeutics FAQs
-
When was Eleven Therapeutics founded?
Eleven Therapeutics was founded in 2020.
-
Where is Eleven Therapeutics headquartered?
Eleven Therapeutics is headquartered in Cambridge, United Kingdom.
-
What is the size of Eleven Therapeutics?
Eleven Therapeutics has 31 total employees.
-
What industry is Eleven Therapeutics in?
Eleven Therapeutics’s primary industry is Biotechnology.
-
Is Eleven Therapeutics a private or public company?
Eleven Therapeutics is a Private company.
-
What is Eleven Therapeutics’s current revenue?
The current revenue for Eleven Therapeutics is .
-
How much funding has Eleven Therapeutics raised over time?
Eleven Therapeutics has raised $22M.
-
Who are Eleven Therapeutics’s investors?
Innovate UK, Gates Foundation, Entrée Capital, Kindred Capital, and NFX are 5 of 7 investors who have invested in Eleven Therapeutics.
-
Who are Eleven Therapeutics’s competitors?
FibroGen (China), Avalyn Pharma, and Kyntra Bio are competitors of Eleven Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process